137 related articles for article (PubMed ID: 36354691)
21. Feasibility of [
Unterrainer LM; Lindner S; Eismann L; Casuscelli J; Gildehaus FJ; Bui VN; Albert NL; Holzgreve A; Beyer L; Todica A; Brendel M; Cyran CC; Karl A; Stief CG; Ledderose ST; Unterrainer M; Bartenstein P; Wenter V; Kretschmer A
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3571-3580. PubMed ID: 35325283
[TBL] [Abstract][Full Text] [Related]
22. Prospective Comparison of
Lan L; Zhang S; Xu T; Liu H; Wang W; Feng Y; Wang L; Chen Y; Qiu L
Radiology; 2022 Sep; 304(3):648-657. PubMed ID: 35579524
[TBL] [Abstract][Full Text] [Related]
23. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
24. Static and Dynamic
Lang M; Spektor AM; Hielscher T; Hoppner J; Glatting FM; Bicu F; Hackert T; Heger U; Pausch T; Gutjahr E; Rathke H; Giesel FL; Kratochwil C; Tjaden C; Haberkorn U; Röhrich M
J Nucl Med; 2023 Feb; 64(2):244-251. PubMed ID: 35906094
[TBL] [Abstract][Full Text] [Related]
25. The Application of [
Zhang H; An J; Wu P; Zhang C; Zhao Y; Tan D; Shi C; Ge X
Contrast Media Mol Imaging; 2022; 2022():6596702. PubMed ID: 36051919
[TBL] [Abstract][Full Text] [Related]
26. Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
Karbhari A; Mosessian S; Trivedi KH; Valla F; Jacobson M; Truty MJ; Patnam NG; Simeone DM; Zan E; Brennan T; Chen H; Kuo PH; Herrmann K; Goenka AH
PLoS One; 2023; 18(11):e0294564. PubMed ID: 38011131
[TBL] [Abstract][Full Text] [Related]
27. Improved cancer detection in Waldeyer's tonsillar ring by
Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
[TBL] [Abstract][Full Text] [Related]
28. Head-to-head comparison of [
Kuten J; Levine C; Shamni O; Pelles S; Wolf I; Lahat G; Mishani E; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):743-750. PubMed ID: 34302504
[TBL] [Abstract][Full Text] [Related]
29. [
Zhu Z; Cheng K; Yun Z; Zhang X; Hu X; Liu J; Wang F; Fu Z; Yue J
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3425-3438. PubMed ID: 37328622
[TBL] [Abstract][Full Text] [Related]
30. Clinical prospective study of Gallium 68 (
Jinghua L; Kui X; Deliang G; Bo L; Qian Z; Haitao W; Yaqun J; Dongde W; Xigang X; Ping J; Shengli T; Zhiyong Y; Yueming H; Zhonglin Z; Yong H; Yufeng Y
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2152-2166. PubMed ID: 36809426
[TBL] [Abstract][Full Text] [Related]
31. 68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.
Alçın G; Arslan E; Aksoy T; Cin M; Erol Fenercioğlu Ö; Beyhan E; Ergül N; Çermik TF
Clin Nucl Med; 2023 Sep; 48(9):e420-e430. PubMed ID: 37351868
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the diagnostic efficacy of
Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
[TBL] [Abstract][Full Text] [Related]
33. The performance of
Jiang Y; Wen B; Li C; Tian Y; Xiao Z; Xu K; Xing D; Yu Z; Huang J; Jia J; He Y
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2114-2126. PubMed ID: 36808001
[TBL] [Abstract][Full Text] [Related]
34. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
35. Superiority of [
Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
[TBL] [Abstract][Full Text] [Related]
36. Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.
Qin C; Song Y; Gai Y; Ruan W; Liu Q; Liu F; Zheng D; Zhang P; Liu H; Zhang T; Tao K; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4228-4240. PubMed ID: 35657428
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.
Hirmas N; Hamacher R; Sraieb M; Ingenwerth M; Kessler L; Pabst KM; Barbato F; Lueckerath K; Kasper S; Nader M; Schildhaus HU; Kesch C; von Tresckow B; Hanoun C; Hautzel H; Aigner C; Glas M; Stuschke M; Kümmel S; Harter P; Lugnier C; Uhl W; Niedergethmann M; Hadaschik B; Grünwald V; Siveke JT; Herrmann K; Fendler WP
J Nucl Med; 2023 May; 64(5):711-716. PubMed ID: 36581374
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
[TBL] [Abstract][Full Text] [Related]
39. Head-to-Head Comparison of
Promteangtrong C; Siripongsatian D; Jantarato A; Kunawudhi A; Kiatkittikul P; Yaset S; Boonkawin N; Chotipanich C
J Nucl Med; 2022 Aug; 63(8):1155-1161. PubMed ID: 34857655
[No Abstract] [Full Text] [Related]
40. Comparison of
Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]